RecruitingPhase 1NCT05857969

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Studying Gliosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Florida International University
Principal Investigator
Diana Azzam
Florida International University
Intervention
Functional Precision Medicine(device)
Enrollment
65 enrolled
Eligibility
21 years · All sexes
Timeline
2023 – 2028

Study locations (1)

Collaborators

Nicklaus Children's Hospital f/k/a Miami Children's Hospital · First Ascent Biomedical Inc. · National Institute on Minority Health and Health Disparities (NIMHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05857969 on ClinicalTrials.gov

Other trials for Gliosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Gliosarcoma →

← Back to all trials